… of hydroxychloroquine to prevent secondary PCR-confirmed, symptomatic Covid-19 and
SARS-CoV-2 infection in contacts exposed to a PCR-positive case patient with Covid-19 during …

… Our meta-analysis of hydroxychloroquine in hospitalized patients with COVID-19 yields a
nonsignificant RR = 1.10 (95% CI, 0.99-1.23). In hospitalized patients, there is an approximate …

… of hydroxychloroquine (HCQ) for prevention of COVID-19 has been adversely affected by a
widespread conviction that HCQ is not effective for prevention. … of HCQ to prevent COVID-19. …

… COVID-19, no drug has been scrutinized nor generated more scientific and political commentary,
than hydroxychloroquine (… story of HCQ in the COVID-19 pandemic era to understand …

… Moreover, the different preliminary reports of COVID-19 candidate vaccines showcase …
treatment of COVID-19. The available data on immunization options to prevent the COVID-19 are …

… CQ/HCQ in clinical settings during the 1st wave of COVID-19, current data from well-designed …
COVID-19 patients. Therefore, we do not recommend the use of this regimen in COVID-19 …

… Prevention of transmission of the disease in the population, particularly among high-risk
individuals, is the urgent need of the hour. Different drugs for prophylaxis against …

… hydroxychloroquine could potentially be used as postexposure prophylaxis, to prevent
symptomatic infection after exposure to Covid-19… the efficacy of hydroxychloroquine as Covid-19 …

… hydroxychloroquine were among the first drugs considered for treatment of coronavirus disease
2019 (COVID-19) … or chloroquine, or both, for the treatment and prevention of COVID-19. …

… of hydroxychloroquine (≥3 days in most participants) suggests that what was being assessed
was prevention of symptoms or progression of Covid-19, rather than prevention of SARS-…